AstraZeneca lifts 2022 earnings outlook as cancer drugs boost results
By Natalie Grover (Reuters) -AstraZeneca raised its full-year earnings outlook on Thursday after strong sales of its key cancer drugs ..
Headlines
All Posts
By Natalie Grover (Reuters) -AstraZeneca raised its full-year earnings outlook on Thursday after strong sales of its key cancer drugs ..
Headlines
By Sheila Dang (Reuters) – Election misinformation is spreading across social media platforms like Twitter and Meta PlatformR..
Headlines
By Gabriella Borter and Tim Reid BIRMINGHAM, Mich./PHOENIX, Ariz. (Reuters) – Republicans made modest gains in U.S. midterm elec..
Headlines
By Herbert Lash NEW YORK (Reuters) – World stocks slid below recent seven-week highs and the dollar rose on Wednesday as investo..
Headlines
By James Davey and Sarah Young LONDON (Reuters) -British consumers are trying to navigate the hit to their finances by spreading out t..
Headlines
By Dawn Chmielewski and Lisa Richwine (Reuters) – Walt Disney Co said on Tuesday its marquee streaming service, Disney+, gained ..
Headlines
World-leading biometrics company, Fingerprint Cards AB (Fingerprints™) has entered a partnership with global card manufacturer, Tag Sy..
Technology
(Reuters) – European countries are facing strikes and protests due to high energy prices and mounting costs of living. Here are ..
Headlines
By Matt Tracy NEW YORK (Reuters) – Elon Musk’s revelation that Twitter has suffered a “massive” revenue drop s..
Headlines
By Laurie Goering SHARM EL-SHEIKH, Egypt (Thomson Reuters Foundation) – Warned that mounting economic crises should not delay ac..
News